Published in J Allergy Clin Immunol on July 30, 2008
Regulatory T cells in asthma. Immunity (2009) 2.00
Mast cell degranulation breaks peripheral tolerance. Am J Transplant (2009) 1.94
Anti-Asthma Simplified Herbal Medicine Intervention-induced long-lasting tolerance to allergen exposure in an asthma model is interferon-γ, but not transforming growth factor-β dependent. Clin Exp Allergy (2010) 1.55
Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol (2010) 1.29
Chronic inflammation and asthma. Mutat Res (2009) 1.22
Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy (2012) 1.20
Macrophages: regulators of sex differences in asthma? Am J Respir Cell Mol Biol (2009) 1.15
Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β. J Immunol (2011) 1.12
Pathogenesis of allergic airway inflammation. Curr Allergy Asthma Rep (2010) 1.11
Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov (2009) 1.10
CD4+ cells are required for chronic eosinophilic lung inflammation but not airway remodeling. Am J Physiol Lung Cell Mol Physiol (2008) 1.07
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma. J Immunol (2010) 1.07
Update in the mechanisms of allergen-specific immunotheraphy. Allergy Asthma Immunol Res (2010) 1.07
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest (2010) 1.03
Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc Natl Acad Sci U S A (2010) 1.03
TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway. Allergy Asthma Clin Immunol (2010) 1.02
Advances in mechanisms of asthma, allergy, and immunology in 2008. J Allergy Clin Immunol (2009) 0.98
1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses. Immunology (2010) 0.96
Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells. Allergy Asthma Immunol Res (2012) 0.94
TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice. PLoS One (2013) 0.93
T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7-/- mice. Fibrogenesis Tissue Repair (2010) 0.93
Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Crit Rev Immunol (2013) 0.90
Harnessing regulatory T cells to suppress asthma: from potential to therapy. Am J Respir Cell Mol Biol (2010) 0.89
Tolerizing allergic responses in the lung. Mucosal Immunol (2010) 0.88
Absence of Foxp3+ regulatory T cells during allergen provocation does not exacerbate murine allergic airway inflammation. PLoS One (2012) 0.87
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice. Thorax (2014) 0.86
Altered regulation of aquaporin gene expression in allergen and IL-13-induced mouse models of asthma. Cytokine (2009) 0.85
Cytotoxic T lymphocyte antigen 4 immunoglobulin modified dendritic cells attenuate allergic airway inflammation and hyperresponsiveness by regulating the development of T helper type 1 (Th1)/Th2 and Th2/regulatory T cell subsets in a murine model of asthma. Clin Exp Immunol (2011) 0.85
HSP70/CD80 DNA vaccine inhibits airway remodeling by regulating the transcription factors T-bet and GATA-3 in a murine model of chronic asthma. Arch Med Sci (2013) 0.84
Regulatory T Cells Control Immune Responses through Their Non-Redundant Tissue Specific Features. Front Immunol (2013) 0.84
Th9 and other IL-9-producing cells in allergic asthma. Semin Immunopathol (2016) 0.84
Bee venom phospholipase A2 suppresses allergic airway inflammation in an ovalbumin-induced asthma model through the induction of regulatory T cells. Immun Inflamm Dis (2015) 0.83
Immunological mechanisms for desensitization and tolerance in food allergy. Semin Immunopathol (2012) 0.83
Schistosoma mansoni-mediated suppression of allergic airway inflammation requires patency and Foxp3+ Treg cells. PLoS Negl Trop Dis (2013) 0.81
Depletion of regulatory T cells augments a vaccine-induced T effector cell response against the liver-stage of malaria but fails to increase memory. PLoS One (2014) 0.81
Bystander immunotherapy as a strategy to control allergen-driven airway inflammation. Mucosal Immunol (2014) 0.79
Regulatory T cells in lung transplantation--an emerging concept. Semin Immunopathol (2011) 0.79
The effect of oral tolerance on the allergic airway response in younger and aged mice. J Asthma (2013) 0.78
Experimental advances in understanding allergic airway inflammation. Front Biosci (Schol Ed) (2013) 0.77
Inhaled corticosteroid use is associated with increased circulating T regulatory cells in children with asthma. Clin Mol Allergy (2013) 0.77
Novel developments in the mechanisms of immune tolerance to allergens. Hum Vaccin Immunother (2012) 0.76
γδT cells regulate chronic airway inflammation and development of airway remodelling. Clin Exp Allergy (2014) 0.75
Reduction of Airway Hyperresponsiveness by KWLL in Dermatophagoides-pteronyssinus-Challenged Mice. Evid Based Complement Alternat Med (2013) 0.75
Ketamine Inhalation Ameliorates Ovalbumin-Induced Murine Asthma by Suppressing the Epithelial-Mesenchymal Transition. Med Sci Monit (2016) 0.75
Anti-inflammatory effects of Boletus edulis polysaccharide on asthma pathology. Am J Transl Res (2016) 0.75
Thermoneutral housing temperature regulates T-regulatory cell function and inhibits ovabumin-induced asthma development in mice. Sci Rep (2017) 0.75
Regulatory T Cells in Allergy and Asthma. Front Pediatr (2017) 0.75
Chimeric Antigen Receptor-Redirected Regulatory T Cells Suppress Experimental Allergic Airway Inflammation, a Model of Asthma. Front Immunol (2017) 0.75
Interleukin-13: central mediator of allergic asthma. Science (1998) 14.05
Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med (1999) 10.67
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet (2002) 8.57
A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med (1996) 6.73
Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol (2003) 5.94
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med (2001) 5.56
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med (1996) 4.54
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med (2005) 3.48
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest (2003) 3.16
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet (2004) 3.05
CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med (2005) 3.03
Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest (2005) 2.94
Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J Autoimmun (2001) 2.49
Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum (2005) 2.32
Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med (2003) 2.32
Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med (2005) 2.26
Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol (2005) 2.22
Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J (2004) 2.18
Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy (2004) 2.00
TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol (2005) 1.85
Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med (2007) 1.63
Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol (2007) 1.63
Role of regulatory T cells in human diseases. J Allergy Clin Immunol (2005) 1.52
Eosinophils: 'new' roles for 'old' cells. Allergy (2004) 1.27
CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol (2006) 1.25
Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. J Immunol (2001) 1.12
Is interleukin-13 critical in maintaining airway hyperresponsiveness in allergen-challenged mice? Am J Respir Crit Care Med (2004) 1.07
Airway wall remodelling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol (2005) 0.91
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med (2002) 4.67
Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med (2005) 3.48
The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol (2003) 3.22
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet (2004) 3.05
Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest (2005) 2.94
The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med (2011) 2.87
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med (2008) 2.44
IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med (2010) 2.36
Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol (2005) 2.22
Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med (2007) 2.08
Activin A and TGF-β promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol (2012) 1.98
Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease. Thorax (2012) 1.88
Orchestrating house dust mite-associated allergy in the lung. Trends Immunol (2011) 1.86
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med (2009) 1.73
Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med (2009) 1.72
The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med (2002) 1.62
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol (2004) 1.49
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol (2012) 1.45
A role for eosinophils in airway remodelling in asthma. Trends Immunol (2004) 1.44
Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am J Respir Crit Care Med (2007) 1.34
Severe asthma treatment: need for characterising patients. Lancet (2005) 1.26
IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax (2012) 1.26
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol (2003) 1.23
Chronic inflammation and asthma. Mutat Res (2009) 1.22
Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol (2004) 1.21
Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease. J Biol Chem (2009) 1.18
Resolution of allergic airway inflammation and airway hyperreactivity is mediated by IL-17-producing {gamma}{delta}T cells. Am J Respir Crit Care Med (2010) 1.15
Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med (2010) 1.14
IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol (2013) 1.14
Regulatory T cells in human disease and their potential for therapeutic manipulation. Immunology (2006) 1.12
Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med (2007) 1.08
Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. J Allergy Clin Immunol (2009) 1.07
Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology (2003) 1.06
Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. Am J Respir Cell Mol Biol (2009) 1.06
Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med (2009) 1.06
CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells (2009) 1.05
CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airways disease. J Immunol (2003) 1.04
Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir Res (2010) 1.01
CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol (2002) 0.99
Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood (2010) 0.98
CCR4 blockade does not inhibit allergic airways inflammation. J Leukoc Biol (2003) 0.97
The role of eosinophils in airway tissue remodelling in asthma. Curr Opin Immunol (2007) 0.96
Asthma: T-bet--a master controller? Curr Biol (2002) 0.96
Transforming growth factor-beta1: its anti-inflammatory and pro-fibrotic effects. Clin Exp Allergy (2002) 0.95
Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol (2004) 0.95
Basal expression of bone morphogenetic protein receptor is reduced in mild asthma. Am J Respir Crit Care Med (2008) 0.94
The eosinophil: the cell and its weapons, the cytokines, its locations. Semin Respir Crit Care Med (2006) 0.92
Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ. J Biol Chem (2012) 0.92
Adenoid-derived TH2 cells reactive to allergen and recall antigen express CC chemokine receptor 4. J Allergy Clin Immunol (2003) 0.88
CXCR1+CD4+ T cells in human allergic disease. J Immunol (2004) 0.83
Eosinophils in the pathogenesis of paediatric severe asthma. Curr Opin Allergy Clin Immunol (2014) 0.82
Innate responsiveness of CD8 memory T-cell populations nonspecifically inhibits allergic sensitization. J Allergy Clin Immunol (2008) 0.81
Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma. Curr Opin Pulm Med (2002) 0.81
Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients. Pediatr Allergy Immunol (2015) 0.80
New strategies for allergen immunotherapy. Recent Pat Inflamm Allergy Drug Discov (2008) 0.79
Dust mites' dirty dealings in the lung. Nat Med (2009) 0.79
Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3. BMC Immunol (2014) 0.78
Lung macrophages contribute to house dust mite driven airway remodeling via HIF-1α. PLoS One (2013) 0.78
Cost advantages of combination asthma therapy. Treat Respir Med (2004) 0.75
Regulatory T cells as a target for induction of immune tolerance in allergy. Curr Opin Allergy Clin Immunol (2005) 0.75